Three-dimensional (3D) power Doppler ultrasound helps differentiate malignant and benign breast lesions, according to a report in the November issue of Radiology.
Three-dimensional (3D) power Doppler ultrasound helps differentiate malignant and benign breast lesions, according to a report in the November issue of Radiology.
Gerald L. LeCarpentier, PhD, of the University of Michigan in Ann Arbor, and colleagues examined the usefulness of a 3D Doppler ultrasound exam to distinguish benign and malignant lesions among women scheduled for a core or excisional biopsy of the breast due to a suspicious breast mass.
Overall, 78 women between the ages of 26 and 70 had the 3D ultrasound and were biopsied. 3D Doppler ultrasound had a sensitivity of 100% in identifying malignant tumors and a specificity of 86% in excluding benign tumors when used in combination with age-based assessment and gray scale visual analysis, the researchers report.
“Using 3D scans promises greater accuracy due to more consistent sampling over the entire tumor,” said LeCarpentier in a statement. “Using speed-weighted 3D power Doppler ultrasound, higher flow velocities in the malignant tumor-feeding vessels may be detected, whereas vessels with slower flow velocities in surrounding benign masses may be excluded.”
LeCarpentier GL, Roubidoux MA, Fowlkes JB, et al. Suspicious breast lesions: assessment of 3D Doppler US indexes for classification in a test population and fourfold cross-validation scheme. Radiology. 2008;249:463-470. DOI:10.1148/radiol.2492060888.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More